Aportaciones y Limitaciones del DSM-5 desde la Psicología Clínica

  1. Enrique Echeburúa
  2. Karmele Salaberría
  3. Marisol Cruz-Sáez
Journal:
Terapia psicológica

ISSN: 0716-6184,  0718-4808

Year of publication: 2014

Volume: 32

Issue: 1

Pages: 65-74

Type: Article

DOI: 10.4067/S0718-48082014000100007 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Terapia psicológica

Abstract

The recent release of the Diagnostic and Statistical Manual of Mental Disorders (5th edition) by the American Psychiatric Association has led to much debate. An effective classification requires a reliable and valid system for categorization of clinical phenomena in order to aid communication, select interventions, indicate aetiology, predict outcomes, and provide a basis for research. DSM-5 remains a categorical classification of separate disorders, but mental disorders do not always fit completely within the boundaries of a single disorder. There are some interesting contributions of DSM-5, such as the chapters of addictions and of personality disorders. Addiction label has also been given to behavioral excesses that have no external substance as a goal (e.g. gambling disorder). Personality disorders remain unchanged, but there is an alternative model in Section III based on a dimensional approach which might replace the current categories. The basic reason for controversy is the expansiveness of DSM-5 psychiatric diagnosis, both in terms of newly introduced categories and loosening the criteria for diagnosis in existing categories. Unanswered questions for future research in this field are commented upon.

Bibliographic References

  • (1952). Diagnostic and statistical manual: Mental disorders. Washington, DC.
  • (2000). DSM-IV-TR: Diagnostic and statistical manual of mental disorders. Washington, DC.
  • (2013). DSM-5: Diagnostic and statistical manual of mental disorders. Washington, DC.
  • Barker, P. (2011). Mental health ethics: The human context. Routledge. Abingdon^eNY NY. 139-148
  • Boyle, M. (2013). Madness contested: Power and practice. PCCS Books. Ross-on-Wye. 3-22
  • Bracken, P, Thomas, P, Timimi, S, Asen, E, Behr, G, Beuster, C. (2012). Psychiatry beyond the current paradigm. Bristish Journal of Psychiatry. 201. 430-434
  • (2011). Response to the American Psychiatric Association: DSM-5 development. British Psychological Society. Leicester.
  • Carlat, D. (2010). Unhinged: The Trouble with Psychiatry - A Doctor's Revelations about a Profession in Crisis. New York.
  • Echeburúa, E. (2010). The challenge of posttraumatic stress disorder prevention: how to survive a disaster?. Terapia Psicológica. 28. 147-154
  • Echeburúa, E, Fernández-Montalvo, J. (2007). Male batterers with and without psychopathy: An exploratory study in Spanish prisons. International Journal of Offender Therapy and Comparative Criminology. 51. 254-263
  • Echeburúa, E, Salaberría, K, Corral, P, Cruz-Sáez, M. S. (2012). Funciones y ámbitos de actuación del psicólogo clínico y del psicólogo general sanitario: una primera reflexión. Behavioral Psychology/Psicología Conductual. 20. 423-435
  • Echeburúa, E, Salaberría, K, Corral, P, Polo-López, R. (2010). Terapias psicológicas basadas en la evidencia: limitaciones y retos de futuro. Revista Argentina de Clínica Psicológica. 19. 247-256
  • Esbec, E, Echeburúa, E. (2010). Violencia y trastornos de la personalidad: implicaciones clínicas y forenses. Actas Españolas de Psiquiatría. 38. 249-261
  • Esbec, E, Echeburúa, E. (2011). La reformulación de los trastornos de la personalidad en el DSM-V. Actas Españolas de Psiquiatría. 39. 1-11
  • Ezama, E, Alonso, Y, Fontanil, Y. (2010). Pacientes, síntomas, trastornos, organicidad y psicopatología. International Journal of Psychology and Psychological Therapy. 10. 293-314
  • Fernández-Montalvo, J, Echeburúa, E. (2008). Trastornos de personalidad y psicopatía en hombres condenados por violencia grave contra la pareja. Psicothema. 20. 193-198
  • Frances, A. (2013). Saving Normal: An Insider 's Revolt Against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. William MorrowHarperCollins Publishers. London.
  • Gili, M, Roca, M, Serrano, M. J. (2006). Trastornos mentales e hiper-frecuentación en atención primaria. INFOCOP.
  • (2006). Encuesta Nacional de Salud.
  • Kraemer, H. C, Kupfer, D. J, Clarke, D. E, Narrow, W. E, Regier, D. A. (2012). DSM-5: how reliable is reliable enough?. American Journal of Psychiatry. 169. 13-15
  • (2006). The Depression Report: A new deal for depression and anxiety disorders. The Centre for Economic Performance's Mental Health Policy Group. London.
  • McGorry, P. D. (2010). Risk syndromes, clinical staging and DSM-V: new diagnostic infrastructure for early intervention in psychiatry. Schizophrenia Research. 120. 49-53
  • Nemeroff, C. B, Weinberger, D, Rutter, M, MacMillan, H. L, Bryant, R. A, Wessely, S. (2013). DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions. BMC Medicine. 11. 202
  • Olesen, J, Gustavsson, A, Svensson, M, Wittchen, H. U, Jönsson, B. (2012). On behalf of the CDBE2010 Study Group and the European Brain Council The economic cost of brain disorders in Europe. European Journal of Neurology. 19. 155-162
  • Ortiz, A, González, R, Rodríguez, F. (2006). La derivación a salud mental de pacientes sin un trastorno psíquico diagnosticable. Atención Primaria. 38. 563-569
  • Sandín, B. (2013). DSM-5: ¿Cambio de paradigma en la clasificación de los trastornos mentales?. Revista de Psicopatología y Psicología Clínica. 18. 255-286
  • Szyf, M, Bick, J. (2013). DNA methylation: A mechanism for embedding early life experiences in the genome. Child Development. 84. 49-57
  • Wakefield, J. C, First, M. B. (2012). Does the empirical evidence support the proposal to eliminate the major depression "bereavement exclusion" in DSM-5?. World Psychiatry. 11. 3-10
  • Wittchen, H. U, Jacobi, F, Rehm, J, Gustavsson, A, Svensson, M, Jönsson, B. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology. 21. 655-679
Data source: Dialnet